Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

U.S. surpasses 10 million COVID-19 vaccinations nationwide

Published 01/13/2021, 03:31 PM
Updated 01/13/2021, 10:56 PM
© Reuters. New York State COVID-19 vaccination site at Jacob K. Javits Convention Center, in New York City

By Peter Szekely and Dan Whitcomb

(Reuters) - More than 10 million Americans have received their first dose of a COVID-19 vaccine as of Wednesday, according to the U.S. Centers for Disease Control and Prevention, as the year-old pandemic roared on unchecked.

The United States reached 10.2 million inoculations one day after the CDC and Trump administration gave new guidance to U.S. states on who should receive the shots first. Strict rules putting healthcare workers first in line had slowed the rollout. Now states are urged to vaccinate anyone over 65 as well.

The milestone came as the United States set a new record for coronavirus deaths in one day, with 4,336 fatalities on Tuesday, according to a Reuters tally.

Health and Human Services Secretary Alex Azar on Tuesday said the administration was releasing its full stockpile of two vaccines approved for emergency use, including some that had been held in reserve to make sure that second doses could be given on schedule.

Nearly 30 million doses of the vaccines, manufactured by Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) with its German partner BioNTech, have been released to U.S. states, which have used only about one-third of them.

Johnson & Johnson (NYSE:JNJ) said on Wednesday that the pharmaceutical company was on track to roll out its single-shot vaccine in March

In an interview with Reuters on Tuesday, Dr. Paul Stoffels also said J&J expected to meet its stated target of delivering 1 billion doses of its vaccine by the end of this year as the company ramps up production.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Political leaders and health officials nationwide have scrambled in recent days to push out more vaccines to their residents, many lowering the age requirement to 65. California and New York have both pledged to inoculate one million residents this month.

NEW YORK SEEKS MORE VACCINE

In New York City, Mayor Bill de Blasio, a Democrat, said on Wednesday that short supplies of the vaccine could hamper efforts to reach the city's inoculation goals.

"We need the federal government, the state government and the manufacturers to step up and get us more supply immediately,” de Blasio told a news conference.

The nation's most populous city is adding vaccination sites across its five boroughs, including its two Major League Baseball stadiums.

"I confirmed with our healthcare team yesterday that even with normal supplies that we expect to have delivered next week, we will run out of vaccine at some point next week, unless we get a major new resupply," de Blasio said.

Public health officials say so far no U.S. state has used up its supply of the vaccines.

At the Javits Center in Manhattan, which was pressed into service as a temporary hospital in April, health officials said they were prepared to vaccinate 10,000 people in 12 hours, with the ability to ramp up to 25,000 in a 24-hour period.

New York has recorded nearly 40,000 coronavirus fatalities since the pandemic broke out there in March, more than any other U.S. state.

Nationwide more than 380,000 people have died of COVID-19. A total of 22.7 million have been infected during that time.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The number of COVID-19 patients requiring hospitalization may have leveled off at least temporarily, according to a Reuters tally, although public health officials warned that further spread may still be seen from holiday gatherings.

California, the nation's most populous state, has seen new hospitalizations drop this week, according to health officials. More than 30,000 Californians have so far died of COVID-19 related illness.

The recent emergence of a more infectious variant of the virus first seen in the United Kingdom has made efforts to accelerate vaccinations all the more important. The so-called UK variant has so far been confirmed in at least 10 U.S. states.

Latest comments

Lockdowns forever for a strain of flu... makes half the country poor... ushers in new age of depemding on government to send yoy 600$ every six monthes... all so some people could ha e power im a far away lamd over you... if they thought the capitol was bad... they are trying to create a movement against all elitiest in washington and government
and still lockdowns? I thought the vaccine was our golden goose?
More bs man. Remember when shutdowns were only supposed to last until they could shore up the hospitals?? Not sure what they're waiting for. Coulda built 1000 auxiliary hospitals by now. Still going on about lack of ICU beds, and people swallow it up.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.